SwitchGear Genomics
	Provider of products for studying gene regulation in the human genome. The company develops new insights into gene regulatory networks, allowing researchers to screen entire pathways in living cells.
	['', 'human genome', ' ', 'gene regulation', ' ', 'gene regulatory networks', ' ', 'living cells', '']
Tissue Repair Company
	Operator of biopharmaceutical company with a clinical-stage focus on products that promote tissue repair. The company\'s scientific expertise is based on gene therapy, growth factor biology, tissue regeneration and product development.
	['', 'tissue repair', ' ', 'tissue regeneration', ' ', 'gene therapy', '']
Voyager Therapeutics
	Provider of gene therapies for diseases of the central nervous system. The company is a gene therapy company that develops treatments for fatal and debilitating diseases of the central nervous system.
	['', 'gene therapy', ' ', 'central nervous system', ' ', 'adreno virus', '']
Elitra Phramaceuticals
	Developer of next generation antimicrobial drugs that target essential gene products of pathogenic organisms. The company employs its functional genomics technologies to identify essential gene drug targets in clinically relevant bacterial and fungal pathogens.
	['', 'antimicrobial drug', ' ', 'drug discovery', ' ', 'pathogenic organism', '']
RGene Therapeutics
	Developer of gene therapy and other nucleic acid-based drugs. The company intends to develop and commercialize gene therapies for in-vivo approaches to ovarian and breast cancer, an ex-vivo anti-sense treatment for chronic myelogenous leukemia and other applications of its gene and nucleic acid delivery systems.
	['', 'gene therapy', ' ', 'nucleic acid', ' ', 'breast cancer', ' ', 'chronic myelogenous leukemia', '']
Spark Therapeutics
	Developer of gene therapy products. The company develops gene therapy products to address debilitating diseases including retinal dystrophies.
	['', 'gene therapy', ' ', 'disease treatment', ' ', 'medical research', '']
REGENXBIO
	Operator of an adeno-associated virus gene therapy company. The company develops proprietary gene therapy tech to advance treatments for lysosomal storage disorders and ocular diseases, as well as other serious diseases.
	['', 'gene therapy', ' adeno-associated ', 'viral vector', ' ', 'clinical trail', '']
Somatix Therapy
	Developer of gene therapy. The company engages in research, development and commercialization of proprietary processes for the genetic modification of cells and their use in the treatment of human disease.
	['genetic ', 'gene therapy', '']
Dimension Therapeutics
	Developer of gene therapies for rare diseases. The company develops novel treatment and focus on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia and building out a world-class product engine for adeno-associated virus (AAV) therapeutics.
	['', 'novel treatment', ' ', 'gene therapy', ' ', 'clinical development', '']
